Relationship between Methylation Status of Multi-drug Resistance Protein (MRP) and Multi-drug Resistance in Lung Cancer Cell Lines

被引:0
作者
Li, Hong [2 ]
Zhu, Yi-Fei [1 ]
Zheng, Shi-Ying [1 ]
Jiang, Dong [1 ]
机构
[1] Suzhou Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Suzhou 215006, Jiangsu Prov, Peoples R China
[2] Suzhou Univ, Affiliated Hosp 1, Dept Geriatr, Suzhou 215006, Jiangsu Prov, Peoples R China
来源
2009 INTERNATIONAL CONFERENCE ON FUTURE BIOMEDICAL INFORMATION ENGINEERING (FBIE 2009) | 2009年
关键词
Lung cancer; Multi-drug resistance protein(MRP); Methylation Multi-drug resistance(MDR); CPG HYPERMETHYLATION; PROSTATE-CANCER; PROMOTER REGION; GENE; ALPHA;
D O I
10.1109/FBIE.2009.5405779
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Objective: To study the relationship between the methylation status of multi-drug resistance protein (MRP) gene and the expression of its mRNA and protein in lung cancer cell lines. Methods:Human lung cell line WI-38.lung adenocarcinoma cell line SPCA-1 and its drug-resistant cells induced by different concentrations of doxorubicin were treated with restriction endonuclease Eco47III.The methylation status of MRP was examined by PCR,and the expressions of its mRNA and protein were evaluated by in situ hybridization and immunohistochemistry. Resuits: MRP gene promoter region of WI-38 cells was in hypermethylation status.but the promoter region of MRP in SPCA-1 cells and their resistant derivatives induced by different concentrations of doxorubicin were in hypomethylation status.There were Significant differences in the expression of MRP mRNA among WI-38 cell line.SPCA-1 cells and their drug-resistan t derivatives induced by different con- centration of doxorubicin.Consistently.MRP immunostaining presented similar significant differences. Conclusion:The promoter region of MRP in SPCA-1 lung adenocarcinoma cells was in hypomethylation status. The hypomethylation status of regulatory region of MRP promoter is an important structural basis that can increase the activity of transcrip-tion and results in the development of drug resistan cc in lung cancer.
引用
收藏
页码:548 / +
页数:2
相关论文
共 50 条
  • [21] A Wireless, CRISPR-Polymer Dot Electrochemical Sensor for the Diagnosis of Bacterial Pneumonia and Multi-Drug Resistance
    Im, San Hae
    Robby, Akhmad Irhas
    Choi, Heewon
    Chung, Ju Yeon
    Kim, Yang Soo
    Park, Sung Young
    Chung, Hyun Jung
    ACS APPLIED MATERIALS & INTERFACES, 2024, 16 (05) : 5637 - 5647
  • [22] Transfer and Persistence of a Multi-Drug Resistance Plasmid in situ of the Infant Gut Microbiotain the Absence of Antibiotic Treatment
    Gumpert, Heidi
    Kubicek-Sutherland, Jessica Z.
    Porse, Andreas
    Karami, Nahid
    Munck, Christian
    Linkevicius, Marius
    Adlerberth, Ingegerd
    Wold, Agnes E.
    Andersson, Dan I.
    Sommer, Morten O. A.
    FRONTIERS IN MICROBIOLOGY, 2017, 8
  • [23] Discovery of peptide drug carrier candidates for targeted multi-drug delivery into prostate cancer cells
    Bashari, O.
    Redko, B.
    Cohen, A.
    Luboshits, G.
    Gellerman, G.
    Firer, M. A.
    CANCER LETTERS, 2017, 408 : 164 - 173
  • [24] Multi-drug resistant Escherichia coli in diarrhoeagenic foals: Pulsotyping, phylotyping, serotyping, antibiotic resistance and virulence profiling
    Kennedy, C. A.
    Walsh, C.
    Karczmarczyk, M.
    O'Brien, S.
    Akasheh, N.
    Quirke, M.
    Farrell-Ward, S.
    Buckley, T.
    Fogherty, U.
    Kavanagh, K.
    Parker, C. T.
    Sweeney, T.
    Fanning, S.
    VETERINARY MICROBIOLOGY, 2018, 223 : 144 - 152
  • [25] Comparative genomics of five different resistance plasmids coexisting in a clinical multi-drug resistant Citrobacter freundii isolate
    Ouyang, Jing
    Sun, Fengjun
    Zhou, Dongsheng
    Feng, Jiao
    Zhan, Zhe
    Xiong, Zhijian
    Yang, Bo
    Liu, Zhirui
    Li, Tingbo
    Tong, Yigang
    Xia, Peiyuan
    INFECTION AND DRUG RESISTANCE, 2018, 11 : 1447 - 1460
  • [26] The complete nucleotide sequence of the multi-drug resistance-encoding IncL/M plasmid pACM1
    Preston, Karen E.
    Hitchcock, Sandra A.
    Aziz, Abdullah Y.
    Tine, John A.
    PLASMID, 2014, 76 : 54 - 65
  • [27] Carbapenem and Colistin Resistance, Integrons and Plasmid Replicon Types in Multi-Drug Resistant Klebsiella Strains Isolated in Turkey
    Kalayci-Yuksek, Fatma
    Gumus, Defne
    Uyanik-Ocal, Aysun
    Gun, Gokhan
    Bayirli-Turan, Derya
    Macunluoglu, Asli-Ceren
    Nakipoglu, Yasar
    Ang-Kucuker, Mine
    CLINICAL LABORATORY, 2022,
  • [28] Molecular detection of fluoroquinolone-resistance in multi-drug resistant tuberculosis in Cambodia suggests low association with XDR phenotypes
    Surcouf, Corinne
    Heng, Seiha
    Pierre-Audigier, Catherine
    Cadet-Daniel, Veronique
    Namouchi, Amine
    Murray, Alan
    Gicquel, Brigitte
    Guillard, Bertrand
    BMC INFECTIOUS DISEASES, 2011, 11
  • [29] Genomic insights into the ESBL and MCR-1-producing ST648 Escherichia coli with multi-drug resistance
    Zhang, Huimin
    Seward, Christopher H.
    Wu, Zuowei
    Ye, Huiyan
    Feng, Youjun
    SCIENCE BULLETIN, 2016, 61 (11) : 875 - 878
  • [30] Vitexin induces apoptosis by suppressing autophagy in multi-drug resistant colorectal cancer cells
    Bhardwaj, Monika
    Cho, Hee Jun
    Paul, Souren
    Jakhar, Rekha
    Khan, Imran
    Lee, Seon-Jin
    Kim, Bo-Yeon
    Krishnan, Manigandan
    Khaket, Tejinder Pal
    Lee, Hee Gu
    Kang, Sun Chul
    ONCOTARGET, 2018, 9 (03) : 3278 - 3291